Lyme Disease Diagnosis: Serology

Area of Science:

• Infectious Diseases
• Immunology
• Medical Diagnostics

Background:

• Serological testing is the primary method for confirming Lyme borreliosis.
• Standardized 2-tier testing (STTT) has been widely adopted since the mid-1990s, leading to improved standardization and performance.
• Direct pathogen detection methods have limited utility in diagnosing Lyme borreliosis.

Purpose of the Study:

• To evaluate the diagnostic performance of STTT for Lyme borreliosis across different disease stages.
• To assess the utility of STTT in confirming early, localized, and late or extracutaneous infections.
• To highlight the role of clinical presentation, such as erythema migrans, in guiding diagnosis and treatment decisions.

Main Methods:

• Review of existing literature and performance data for STTT in Lyme borreliosis diagnosis.
• Analysis of STTT sensitivity and specificity for early localized Lyme disease versus late disseminated disease.
• Evaluation of STTT's effectiveness in confirming extracutaneous manifestations of Lyme borreliosis.

Main Results:

• STTT demonstrates poor sensitivity for detecting early, localized Lyme borreliosis.
• STTT exhibits good performance in diagnosing late-stage and extracutaneous Lyme borreliosis.
• Erythema migrans, a hallmark of early infection, is present in most US cases and warrants treatment without initial serological testing.
• Clinical and epidemiological factors are crucial for appropriate STTT ordering.

Conclusions:

• STTT is a valuable tool for confirming Lyme borreliosis, particularly for late and extracutaneous disease.
• Clinical assessment and recognition of erythema migrans are paramount for timely diagnosis and treatment of early Lyme disease.
• Ongoing advancements in diagnostic methods hold promise for enhancing early Lyme disease detection using serology.